Login / Signup

Utilizing artificial intelligence and next-generation sequencing to facilitate the diagnosis of rare diseases.

Felix HallerMaximilian AutherithReinhard LehnerAlice SchmidtGere Sunder-Plaßmann
Published in: Clinical kidney journal (2023)
Keyphrases
  • artificial intelligence
  • machine learning
  • big data
  • deep learning
  • copy number
  • circulating tumor
  • gene expression
  • cell free